Publisher of Iranian Journals and Conference Proceedings

Please waite ..
Publisher of Iranian Journals and Conference Proceedings
Login |Register |Help |عضویت کتابخانه ها
Paper
Title

Biosynthesis of copper nanoparticles and their hybrid with albumin nanoparticles as a nanocarrier for Chrysin transfer and evaluation of its anti-cancer effects in breast MDA-MB-۲۳۱ cancer cell line

پنجمین کنگره بین المللی سرطان
Year: 1400
COI: CANCERMED05_157
Language: EnglishView: 145
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

Authors

Mahmud Gharbavi - Zanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran
Ali Sharafi - Zanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran
Roghayeh Ghorbani - Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
Behrooz Johari - Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

Abstract:

Introduction:Breast cancer is the second leading cause of cancer deaths among women and its prevention remains challenging in the world. Chrysin is a natural flavonoid found abundantly in vegetables and fruits. There is ample evidence that Chrysin has therapeutic potential for the prevention and treatment of various diseases including cardiovascular disease, cancer and neurological diseases. On the other hand, copper (Cu) is one of the nanoparticles of interest in medicine that has anti-cancer properties. This metal has photocatalytic ability and high oxidation capacity against prokaryotic and eukaryotic cells. These nanoparticles have the ability to selectively induce apoptosis on tumor cells as well as being a cancer inhibitory agent.Materials and Methods:In the present study, a hybrid of copper nanoparticles with synthesized albumin nanoparticles was used as a nanocarrier to deliver the anticancer Chrysin drug. The purity of the nanoparticles was authenticated using different characterization techniques, including UV spectroscopy, SEM, EDX and DLS. Moreover, the drug release was successfully performed from the Cu@BSA@Chrysin Nps under ۳۷◦C.Results:The untiprolifration as well as apoptotic activity of the Chrysin-carrying nanoparticles were investigated using MDA-MB-۲۳۱ cells. The results show that Cu@BSA@Chrysin Nps can increase apoptosis and decrease the growth of MDA-MB-۲۳۱ breast cancer cells.Conclusion:It can be concluded that Cu@BSA@Chrysin Nps could potentially suppress the cancerous properties of MDA-MB-۲۳۱ cells and the presented nanocarrier system can be a promising approach for targeted drug delivery in cancer treatment.

Keywords:

Paper COI Code

This Paper COI Code is CANCERMED05_157. Also You can use the following address to link to this article. This link is permanent and is used as an article registration confirmation in the Civilica reference:

https://civilica.com/doc/1377904/

How to Cite to This Paper:

If you want to refer to this Paper in your research work, you can simply use the following phrase in the resources section:
Gharbavi, Mahmud and Sharafi, Ali and Ghorbani, Roghayeh and Johari, Behrooz,1400,Biosynthesis of copper nanoparticles and their hybrid with albumin nanoparticles as a nanocarrier for Chrysin transfer and evaluation of its anti-cancer effects in breast MDA-MB-۲۳۱ cancer cell line,Fifth International Cancer Congress,Tehran,https://civilica.com/doc/1377904

Research Info Management

Certificate | Report | من نویسنده این مقاله هستم

اطلاعات استنادی این Paper را به نرم افزارهای مدیریت اطلاعات علمی و استنادی ارسال نمایید و در تحقیقات خود از آن استفاده نمایید.

Scientometrics

The specifications of the publisher center of this Paper are as follows:
Type of center: علوم پزشکی
Paper count: 1,081
In the scientometrics section of CIVILICA, you can see the scientific ranking of the Iranian academic and research centers based on the statistics of indexed articles.

New Papers

New Researchs

Share this page

More information about COI

COI stands for "CIVILICA Object Identifier". COI is the unique code assigned to articles of Iranian conferences and journals when indexing on the CIVILICA citation database.

The COI is the national code of documents indexed in CIVILICA and is a unique and permanent code. it can always be cited and tracked and assumed as registration confirmation ID.

Support